СОСТОЯНИЕ СЛУЖБЫ ГЕМОДИАЛИЗА В САМАРКАНДСКОЙ ОБЛАСТИ И АНАЛИЗ ВЫЖИВАЕМОСТИ И СМЕРТНОСТИ У ПАЦИЕНТОВ, ПОЛУЧАЮЩИХ ГЕМОДИАЛИЗ
Ключевые слова:
система здравоохранения, гемодиализ, хроническая болезнь почекАннотация
В статье представлено состояние службы гемодиализа в Самаркандской области за последние пять лет, а также приведены данные о количестве пациентов с хронической болезнью почек, получающих заместительную почечную терапию, показатели их выживаемости и смертности.
Библиографические ссылки
Bello, A. K. et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ 367, l5873 (2019).
Benghanem G.M., Elseviers M., Zamd M., et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid ‘over’- and ‘under’-diagnosis of CKD // Kidney Int. - 2016. - Vol. 89. - Р. 1363–1371.
Fraser S.D.S., Roderick P.J., Casey M., Taal M.W., Yuen H.M., Nutbeam D. Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrology Dialysis Transplantation, 2013, vol. 28, no. 1, pp. 129–137. DOI: 10.1093/ndt/gfs371.
Goodkin, D. A. et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. 14, 3270–3277 (2003).
Herrera-Añazco, P., Benites-Zapata, V., Hernandez, A. V., Mezones-Holguin, E. & Silveira- Chau, M. Mortality in patients with chronic kidney disease undergoing hemodialysis in a public hospital of Peru. J. Bras. Nefrol. 37, 192–197 (2015).
Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).
Jack K.C. Ng., Li P.K.-T. Chronic kidney disease epidemic: How do we deal with it? Nephrology, vol. 23, no. 4, pp. 116–120. 2018. https://doi.org/10.1111/nep.13464.
Jardine, T., Wong, E., Steenkamp, R., Caskey, F. J. & Davids, M. R. Survival of South African patients on renal replacement therapy. Clin. Kidney J. 13, 782–790 (2020).
KDIGO Clinical Practice Guideline for Glomerulonephritis // Kidney International Supplements. – 2012. - Vol. 2. - Р. 259–274.
Khazaei, S. et al. Survival rate and predictors of mortality among hemodialysis patients in West of Iran, 1996–2015. Int. J. Prev. Med. 9, 113 (2018).
Kidney Disease: Improving Global Outcomes (KDIGO)& CKD-MBD Work Group. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. Suppl. https://doi.org/10.1038/ki.2009.188 (2009).
Levey, A. S. et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 97, 1117–1129 (2020).
Liu, F. X., Rutherford, P., Smoyer-Tomic, K., Prichard, S.& Laplante, S. A global overview of renal registries: a systematic review. BMC Nephrol. 16, 31 (2015).
Mathur R., Dreyer G., Yaqoob M.M., Hull S.A. Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study. BMJ Open, 2018, vol. 27, no. 8 (3), pp. e020145. DOI:10.1136/bmjopen-2017-020145.
Msaad, R. et al. Predictors of mortality in hemodialysis patients. Pan Afr. Med. J. 33, 61 (2019).
Nordio, M. et al. Survival in patients treated by long-term dialysis compared with the general population. Am. J. Kidney Dis. 59, 819–828 (2012).
Parving H.H., Brenner B.M., McMurray J.J.V, et al, for the ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes // N Engl J Med. 2012. Vol.367. Р. 2204–2213.
Pecoits-Filho, R. et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. 10, e3–e9 (2020).
United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020); ANZDATA Registry. 43rd Report, Chapter 4: Haemodialysis. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA, Adelaide, Australia, 2020.).
Stalpers, Lucas J.A.; Kaplan, Edward L. (May 4, 2018). "Edward L. Kaplan and the Kaplan- Meyer survival curve." Bulletin of the BSHM: Journal of the British Society for the History of Mathematics. 33 (2): 109–135. doi:10.1080/17498430.2018.1450055. S2CID 125941631.
